Hydrolytically processed oligodeoxyribonucleotides and their pha

Details Hydrolytically processed oligodeoxyribonucleotides and their pha Hydrolytically processed oligodeoxyribonucleotides and their pha

1992-12-04

2000-04-04

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 231, 536 254, 536 2541, A61K 3170, C07H 2104

Patent

active

060461721

ABSTRACT:
The invention discloses new oligodeoxyribonucleotides of animal origin, having a molecular weight comprised between 4000 and 10000 daltons, that can be obtained by fractionation of polydeoxyribonucleotides or otherwise by chemical or enzymatic depolymerization of high molecular weight deoxyribonucleic acids. The new compounds are endowed with a significant anti-ischemic activity.

REFERENCES:
patent: 3770720 (1973-11-01), Butti et al.
patent: 3899481 (1975-08-01), Butti et al.
patent: 4417046 (1983-11-01), Hsiung
patent: 4605644 (1986-08-01), Foker
patent: 4623723 (1986-11-01), Keller et al.
patent: 4833239 (1989-05-01), DeBonville et al.
patent: 4985552 (1991-01-01), Fedeli et al.
patent: 4997932 (1991-03-01), Reardon et al.
patent: 5047345 (1991-09-01), DeBonville et al.
patent: 5063162 (1991-11-01), Kiefer
patent: 5126331 (1992-06-01), Gazzani
New England BioLabs Catalog 1990-1991' Beverly Ma. USA, pp. 62, 63, 73, 83 and 132.

Affiliated with

Also associated with

Rating

Hydrolytically processed oligodeoxyribonucleotides and their pha does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydrolytically processed oligodeoxyribonucleotides and their pha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrolytically processed oligodeoxyribonucleotides and their pha will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-365116